Late Breaking Clinical Trials Session

1 Apr 2023 14:15 15:15

Plenary Halls 2 & 3

Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom

Sydney Tang Chairperson The University of Hong KongHong Kong, China

Time	Session

14:15 14:25	STOP-ACEi Study Sunil Bhandari Speaker sunil.bhandari@nhs.netHull & East Yorkshire Hospitals NHS Trust United Kingdom Plenary Halls 2 & 3
14:25 14:30	Q and A Plenary Halls 2 & 3
14:30 14:40	DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL Natalie Staplin Free Communication natalie.staplin@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom Plenary Halls 2 & 3
14:40 14:45	Q and A Plenary Halls 2 & 3
14:45 14:55	SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY Muh Geot Wong Speaker muhgeot.wong@sydney.edu.auUniversity of SydneyAustralia Plenary Halls 2 & 3
14:55 15:00	Q and A Plenary Halls 2 & 3
15:00 15:10	RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS Jianwen YU Free Communication yjwen86@126.comThe First Affiliated Hospital of Sun Yat-sen UniversityChina
15:10 15:15	Q and A Plenary Halls 2 & 3